Clinical Trial Update: Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study comparing gefitinib with olaparib versus gefitinib alone in non-small cell lung cancer has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Iressa (Gefitinib) (Gefitinib)
• Lynparza (Olaparib) (Olaparib)

Snippet

Sponsor: Spanish Lung Cancer Group | Conditions: Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-06-28